Cataract Surgery

John A. Hovanesian, MD, discusses the highlights of his presentation on a clinical study evaluating dexamethasone vs prednisolone acetate 1% in controlling postop pain/inflammation in sequential cataract surgery patients.

Pandemic is driving — and accelerating — changes in how ophthalmic care is delivered to patients.

Innovations have made procedure quick, safe, effective.

Goniotomy-viscodilation cataract surgery controls IOP without medications.

Advances in laser-vision correction provide visual results that often surpass 20/20.

Programs use detection and treatment to ease burden of eye disease.

Robert Weinstock, MD, presents data from a retrospective multicenter study focusing on the efficacy of dexamethasone intraocular suspension 9% delivered at the time of cataract surgery.

Speaking during the American Academy of Ophthalmology’s virtual 2020 annual meeting, Neal H. Shorstein, MD, explained how physicians at Kaiser Permanente have been using a prophylactic drop-free drug regimen before cataract surgery for more than a decade. Their regimen is so streamlined that the only drop that patients receive in anticipation of cataract surgery is a supplemental dilation drop instilled preoperatively while they are still in the holding area.

Rudy Nuijts of the University Eye Clinic Maastricht, the Netherlands, discusses the highlights of his AAO 2020 presentation on a combination treatment regimen for lowering the incidence of cystoid macular oedema following category surgery.

Elevated pressure can lead to irreversible optic nerve damage, vision loss

Optics block out-of-focus and stray light, allow continuum of vision.

Large randomized trial compares efficacy and safety of multiple regimens

Streamlining preoperative process can offer some relief during stressful time

The FEMCAT study found that FLACS is not superior to conventional approach

Newly cleared technology for laser cataract gives ophthalmologists another tool.

A number of options may offer major cost savings, positive results for patients.

Benefits of intracameral phenylephrine/ketorolac continue to add up.

Monofocal toric lens delivers effective astigmatic correction and more, study results show

RLE, in unexpected twist, is gaining support among surgeons

Options can reduce the treatment burden for patients, leading to improved outcomes

Investigators find value in screening for macular disease in preoperative evaluation

Checking own work postoperatively offers value to ophthalmologists

Sharing postoperative care can lead to better work-life balance

Following cataract surgery, the dropless option is proving to be a preferred method during recovery

ICYMI: Alice Epitropoulos, MD, FACS, speaks on "Image quality or depth of field or both: Clinical outcomes from spherical aberration neutral monofocal toric IOL," during the 2020 ASCRS virtual meeting.